New cannulation knife put to the test in central line study
NCT ID NCT06310174
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of knife used to make a small cut when inserting a central venous catheter (a large IV line). Doctors rated how easy and safe the knife was to use, and the team tracked problems like needing to re-cut or restart the procedure. 86 patients and their doctors took part at Johns Hopkins University.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
86 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
A prospective cohort of 100 clinicians will be enrolled. The cannulation knife will be studied in three clinical areas: * Cardiovascular Operating Room * Cardiovascular Surgical Intensive Care Unit * Interventional Cardiology
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient requires a 5 French, 7 French, or 12-14 French central venous catheter. * Operator responsible for insertion of central venous catheter. Exclusion Criteria: * Patient unwilling to consent. * Operator unwilling to complete the survey.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central venous catheter exit site infection are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.